Rabeprazole (rabeprazole): Reviews and patient testimonials

Rabeprazole 10mg Gastro-resistant Tablets

Rabeprazole 10mg Gastro-resistant Tablets are indicated for the treatment of:

• Active duodenal ulcer

• Active benign gastric ulcer

• Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

• Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)

• Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

• Zollinger-Ellison Syndrome

• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2

Rabeprazole 20mg Gastro-resistant Tablets

Rabeprazole 20mg Gastro-resistant Tablets are indicated for the treatment of:

• Active duodenal ulcer

• Active benign gastric ulcer

• Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

• Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)

• Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

• Zollinger-Ellison Syndrome

• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2

Rabeprazole Sodium 10 mg Gastro-resistant tablets

Rabeprazole tablets are indicated for the treatment of:

• Active duodenal ulcer

• Active benign gastric ulcer

• Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

• Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)

• Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

• Zollinger-Ellison Syndrome

Rabeprazole sodium 10 mg gastro-resistant tablets

Rabeprazole sodium tablets are indicated for the treatment of:

- Active duodenal ulcer

- Active benign gastric ulcer

- Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD)

- Gastro-oesophageal reflux disease long-term management (GORD maintenance)

- Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

- Zollinger-Ellison syndrome

- In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2.

Rabeprazole sodium 20 mg Gastro-resistant Tablets

Rabeprazole sodium gastro-resistant Tablet is indicated for the treatment of:

• Active duodenal ulcer

• Active benign gastric ulcer

• Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

• Gastro-oesophageal reflux disease long-term management (GORD Maintenance)

• Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

• Zollinger-Ellison Syndrome

• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. see section 4.2

Rabeprazole sodium 20 mg gastro-resistant tablets

Rabeprazole sodium tablets are indicated for the treatment of:

- Active duodenal ulcer

- Active benign gastric ulcer

- Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD)

- Gastro-oesophageal reflux disease long-term management (GORD maintenance)

- Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

- Zollinger-Ellison syndrome

- In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2.

Rabeprazole Sodium 20mg Gastro-resistant tablets

Rabeprazole tablets are indicated for the treatment of:

• Active duodenal ulcer

• Active benign gastric ulcer

• Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

• Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance)

• Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)

• Zollinger-Ellison Syndrome

Route of administration: Oral
Molecule: rabeprazole